The symptoms of hypoglycaemia are fundamental to the early detection and treatment of this
side‐effect of insulin and oral hypoglycaemic therapy in people with diabetes. The …

Impaired awareness of hypoglycaemia (IAH) is an acquired complication of insulin therapy,
which affects people with type 1 and insulin-treated type 2 diabetes mellitus, whereby the …

Background Human insulin was introduced for the routine treatment of diabetes mellitus in
the early 1980s without adequate comparison of efficacy to animal insulin preparations. First …

Hypoglycaemia is a frequent side-effect of treatment with insulin and sulfonylureas for
people with diabetes, threatening potentially serious morbidity and preventing optimal …

Intensive glycaemic control reduces the diabetic microvascular disease burden but
iatrogenic hypoglycaemia is a major barrier preventing tight glycaemic control because of …

Hypoglycemia is the most common endocrine emergency faced by practicing physicians, the
most frequent complication of insulin-requiring diabetes, and the principal factor limiting …

The 'average'adult with type 1 diabetes will experience many thousands of episodes of mild,
symptomatic hypoglycaemia over a lifetime of treatment with insulin. Severe hypoglycaemia …

Impaired awareness of hypoglycaemia (IAH) is the inability to perceive the onset of the
warning symptoms of hypoglycaemia, which diminish in intensity and number over time; loss …

Better control of the diabetic metabolic state will prevent the diabetes complications.
However in current clinical practice, it is sometimes difficult to achieve this goal. Additionally …

Aims Sudden death in young diabetic patients has been associated with nocturnal
hypoglycaemia perhaps as a result of cardiac dysrhythmias following abnormal cardiac …